Cargando…

Case Report: Subtherapeutic Vancomycin and Meropenem Concentrations due to Augmented Renal Clearance in a Patient With Intracranial Infection Caused by Streptococcus intermedius

Streptococcus intermedius occasionally causes brain abscesses that can be life-threatening, requiring prompt antibiotic and neurosurgical treatment. The source is often dental, and it may spread to the eye or the brain parenchyma. We report the case of a 34-year-old man with signs of apical periodon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fransson, Marcus, Helldén, Anders, Östholm Balkhed, Åse, Nezirević Dernroth, Dženeta, Ha, Maria, Haglund, Mats, Milos, Peter, Hanberger, Håkan, Kågedal, Bertil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527190/ https://www.ncbi.nlm.nih.gov/pubmed/34690767 http://dx.doi.org/10.3389/fphar.2021.728075

Ejemplares similares

Delay of appropriate antibiotic treatment is associated with high mortality in patients with community-onset sepsis in a Swedish setting
por: Andersson, Maria, et al.
Publicado: (2019)

Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study
por: ÖstholmBalkhed, Åse, et al.
Publicado: (2018)

14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality
por: Holmbom, Martin, et al.
Publicado: (2016)

Prehospital delay is an important risk factor for mortality in community-acquired bloodstream infection (CA-BSI): a matched case–control study
por: Holmbom, Martin, et al.
Publicado: (2021)

Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection
por: Holmbom, Martin, et al.
Publicado: (2020)

888. A Predictive Model for Subtherapeutic Vancomycin Troughs in Adults
por: Crisp, Sarah, et al.
Publicado: (2022)

Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
por: Wilson, F. Perry, et al.
Publicado: (2012)

Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study
por: Bakke, V., et al.
Publicado: (2017)

Risk factors and outcome due to extended-spectrum β-lactamase-producing uropathogenic Escherichia coli in community-onset bloodstream infections: A ten-year cohort study in Sweden
por: Holmbom, Martin, et al.
Publicado: (2022)

Cryopreservation of autologous bone flaps following decompressive craniectomy: A new method reduced positive cultures without increase in post-cranioplasty infection rate
por: Melin, Sofia, et al.
Publicado: (2022)

Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study
por: Wahlgren, Carl, et al.
Publicado: (2023)

An investigation of household dogs as the source in a case of human bacteraemia caused by Staphylococcus pseudintermedius
por: Östholm Balkhed, Åse, et al.
Publicado: (2023)

Vancomycin for Dialytic Therapy in Critically Ill Patients: Analysis of Its Reduction and the Factors Associated with Subtherapeutic Concentrations
por: de Freitas, Fernanda Moreira, et al.
Publicado: (2020)

Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Infective Endocarditis
por: Save, Jonathan, et al.
Publicado: (2022)

Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
por: Besnard, Thibaud, et al.
Publicado: (2019)

Acute Cardioembolic Stroke in the Setting of Subtherapeutic Anticoagulation
por: Ambatipudi, Ankit, et al.
Publicado: (2023)

Comparison of Rates of Acute Kidney Injury with Vancomycin/Piperacillin-Tazobactam vs. Vancomycin/Meropenem Combination Therapy
por: Pernia, Sonia, et al.
Publicado: (2017)

Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
por: SRİSRATTAKARN, Arpasiri, et al.
Publicado: (2021)

Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
por: Zylbersztajn, Brenda, et al.
Publicado: (2021)

Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms
por: Wahlgren, Carl, et al.
Publicado: (2021)

Comparison of Intravenous Microdialysis and Standard Plasma Sampling for Monitoring of Vancomycin and Meropenem Plasma Concentrations—An Experimental Porcine Study
por: Lilleøre, Johanne Gade, et al.
Publicado: (2023)

Alternative approaches to therapeutics and subtherapeutics for sustainable poultry production
por: Tabashsum, Zajeba, et al.
Publicado: (2023)

Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
por: Sipahi, Oguz Resat, et al.
Publicado: (2023)

Concentrations of Co-Administered Meropenem and Vancomycin in Spinal Tissues Relevant for the Treatment of Pyogenic Spondylodiscitis—An Experimental Microdialysis Study
por: Slater, Josefine, et al.
Publicado: (2023)

Meropenem clearance by continuous haemofiltration: a comparison of in vivo and in vitro data
por: Giles, LJ, et al.
Publicado: (1999)

Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents
por: Zhang, Tan, et al.
Publicado: (2023)

Differential Impact of Subtherapeutic Antibiotics and Ionophores on Intestinal Microbiota of Broilers
por: Robinson, Kelsy, et al.
Publicado: (2019)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Comparison of Acute Kidney Injury During Treatment with Vancomycin and either Piperacillin-Tazobactam or Meropenem
por: Cannon, John M., et al.
Publicado: (2017)

Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update
por: Schneider, Franziska, et al.
Publicado: (2022)

Endoscopy during neurotomy of the nervus intermedius for nervus intermedius neuralgia: a case report
por: Song, Zhuhuan, et al.
Publicado: (2021)

Chronic Exposure to Subtherapeutic Antibiotics Aggravates Ischemic Stroke Outcome in Mice
por: Dong, Xiao-Hui, et al.
Publicado: (2017)

Dysmorphic contribution of neurotransmitter and neuroendocrine system polymorphisms to subtherapeutic mood states
por: Gonzalez, Irene, et al.
Publicado: (2019)

Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine
por: Kyllesø, Lennart, et al.
Publicado: (2020)

Favipiravir/meropenem/vancomycin: Cholestatic liver injury following off-label use: case report
Publicado: (2021)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
por: Tiede, Christoph, et al.
Publicado: (2021)

Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn’s disease
por: Carlsen, Arne, et al.
Publicado: (2018)

A strategy for effective latent HIV reactivation using subtherapeutic drug doses
por: Cotterell, James, et al.
Publicado: (2017)

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
por: Brüggemann, R.J., et al.
Publicado: (2021)

Subtherapeutic Exposure of Ganciclovir in Children Despite Appropriate Dosing: A Short Communication
por: Marfil, Sjanene, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n718pte494pv5j966pga7bachb